Liver Cancer Clinical Trial
Official title:
Effectiveness of Positioning on Back Pain After Transcatheter Arterial Chemoembolization Among Patients With Hepatocellular Carcinoma
Changing patients' position in the bed after TACE can decrease the level of back pain without increasing the amount of bleeding and hematoma,bring patients some comfort and relieving abdominal bloating, increase patients' satisfaction.
Background:During the treatment for the liver cancer patients who are treated by
Transcatheter Arterial Chemoembolization (TACE), the embolic agent with chemotherapeutic
drugs are injected through a catheter into a femoral artery directly supplying the tumor.
Hence, after the procedure, to avoid bleeding and hematoma at the puncture site, the puncture
site at groin needs to be pressed by sandbag and the affected limb needs to remain straight.
These patients have to lay down on beds and are not allowed to move for at least 4 hours. Due
to pressure exerted continuously to the same muscles, may cause back muscle rigidity and
spasms, these patients may suffer from back pain and discomfort. In addition to usual
pharmacological treatment, nursing intervention aimed at decreasing patient discomfort,
therefore, this study will refer to the previous researches to develop the methods and
procedures of changing body positions and apply these methods to the liver cancer patients
who are treated by TACE.
Purpose:The aim of this study was to compare the level of back pain and on the amount of
bleeding and hematoma between those patients changing body positions in bed and those
patients not changing body positions after TACE.
Methods: This study was a randomized clinical trial. The sample consisted of 78 patients who
had undergone TACE via the femoral artery, patients by using a convenience sampling assigned
to either the control or experimental group (each group consisting 39 participants). All
patients need to be pressed on the puncture site at groin with a sand bag of 2.5 kg for 2
hours and lie down for 4 hours. The control group received the usual care, remaining supine
position in complete bed rest and immobilized. Experimental group patients received position
changes in the second hour and the fourth hour after TACE.
Results: The overall trend of back pain is different between the two groups ( p <.001) , the
mean of pain intensity in the second ( p =.006) and the forth hour ( p <.001) showed a
significant difference. Experimental group patients had significantly less back pain than the
control group after TACE . For the within subjects factor of time, the levels of back pain
differed significantly across the five-time periods in experimental group ( p < .05) . In the
aspect of post embolization syndrome , control group patients had significantly abdominal
bloating than the experimental group ( p =.003) . None of patients developed hematoma, there
was no significant difference between the two groups in terms of amount of bleeding. On the
whole, experimental group patients had significantly higher satisfaction than the control
group ( p =.018).
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03213314 -
HepaT1ca: Quantifying Liver Health in Surgical Candidates for Liver Malignancies
|
N/A | |
Not yet recruiting |
NCT04931420 -
Study Comparing Standard of Care Chemotherapy With/ Without Sequential Cytoreductive Surgery for Patients With Metastatic Foregut Cancer and Undetectable Circulating Tumor-Deoxyribose Nucleic Acid Levels
|
Phase 2 | |
Terminated |
NCT00788125 -
Dasatinib, Ifosfamide, Carboplatin, and Etoposide in Treating Young Patients With Metastatic or Recurrent Malignant Solid Tumors
|
Phase 1/Phase 2 | |
Completed |
NCT03756597 -
PAN-study: Pan-Cancer Early Detection Study (PAN)
|
||
Recruiting |
NCT05160740 -
Indocyanine Green Molecular Fluorescence Imaging Technique Using in Diagnosis and Treatment of Primary Liver Cancer
|
N/A | |
Completed |
NCT01906021 -
Study of New Software Used During Ablations
|
N/A | |
Terminated |
NCT04589884 -
Intraoperative EXamination Using MAChine-learning-based HYperspectral for diagNosis & Autonomous Anatomy Assessment
|
||
Recruiting |
NCT05953337 -
Radioembolization Trial Utilizing Eye90 Microspheres™ for the Treatment of Hepatocellular Carcinoma (HCC)
|
N/A | |
Enrolling by invitation |
NCT04466124 -
Prospective Cohort Study of Liver Cancer Patients Treated With Proton Beam Therapy
|
||
Not yet recruiting |
NCT04053231 -
Hepatocarcinoma Recurrence on the Liver Study - Part2
|
||
Active, not recruiting |
NCT02869217 -
Study of TBI-1301 (NY-ESO-1 Specific TCR Gene Transduced Autologous T Lymphocytes) in Patients With Solid Tumors
|
Phase 1 | |
Completed |
NCT03059238 -
Parecoxib Versus Celecoxib Versus Oxycodone in Pain Control for Transcatheter Chemoembolization Procedure
|
Phase 3 | |
Recruiting |
NCT02632188 -
Radical Surgery Followed by Immunotherapy Using Precision T Cells Specific to Multiple Common Tumor-Associated Antigen for the Treatment of Hepatocellular Carcinoma
|
Phase 1/Phase 2 | |
Recruiting |
NCT01388101 -
Real-time Diagnosis of Serum LECT 2 in Patient With Liver Cancer Using Electronic Antibody Sensor (e- Ab Sensor)
|
N/A | |
Terminated |
NCT00903396 -
Palonosetron Hydrochloride in Preventing Nausea and Vomiting Caused by Radiation Therapy in Patients With Primary Abdominal Cancer
|
Phase 2 | |
Completed |
NCT00980239 -
HAI Irinotecan + IV Bevacizumab, Bevacizumab & Oxaliplatin or Bevacizumab & Cetuximab in Advanced Cancers Metastatic to Liver
|
Phase 1 | |
Completed |
NCT01042041 -
Sorafenib Tosylate and Chemoembolization in Treating Patients With Unresectable Liver Cancer
|
Phase 1 | |
Completed |
NCT00790569 -
Varenicline or Nicotine Patch and Nicotine Gum in Helping Smokers in a Methadone Treatment Program Stop Smoking
|
N/A | |
Terminated |
NCT00896467 -
Psychological and Emotional Impact in Patients Undergoing Treatment For Metastatic Cancer Either in a Clinical Trial or as Standard Off-Trial Therapy
|
N/A | |
Completed |
NCT00543777 -
Magnetic Resonance Elastography and 2-Point Dixon MR Imaging Techniques in Diffuse Liver Disease
|
Phase 1/Phase 2 |